| Bid Price | High Price | ||
|---|---|---|---|
| Ask Price | Low Price | ||
| Open Price | Spread | ||
| Prev Close | Volume |
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2018 | 121.00 | 126.50 | 116.94 | 118.50 | 29,596 |
| Oct 12, 2018 | 119.46 | 120.00 | 118.08 | 117.50 | 14,103 |
| Oct 11, 2018 | 115.00 | 120.00 | 114.50 | 121.50 | 101,962 |
| Oct 10, 2018 | 121.00 | 122.50 | 121.00 | 121.50 | 8,650 |
| Oct 9, 2018 | 121.10 | 123.00 | 120.73 | 121.00 | 49,117 |
| Name | Silence Therapeutics | Epic | SLN |
|---|---|---|---|
| ISIN | GB00B9GTXM62 | Currency | GBX |
| Type | Equity | Trading Segment | AMSM |
| Record Status | Active | Trading Status | Closed |
| Industry | Health Care | Sector | Pharmaceuticals & Biotechnology |
| EMS | 2,000 | Prev Close | 118.50 |
| Shares in Issue (m) | 71.07 | Market Cap (£m) | 83.51 |
| PE Ratio | -51.09 | Div per Share (p) | 0.00 |
| Div Yield | 0.00 | Div Cover | 0.00 |
| EPS | -2.30 | EPS Growth (%) | 80.99 |
| PEG | -0.63 | DPS Growth (%) | n/a |
| ROCE | -7.22 | Net Gearing | -72.88 |
| Quick Ratio | 17.14 | Current Ratio | 17.14 |
| Date | Broker | Recomm. | Price | Old Target | New Target | Notes |
|---|---|---|---|---|---|---|
| 12 Oct | Peel Hunt | Buy | 118.50 | 277.00 | - | Reiterates |
| 10 Oct | Peel Hunt | Buy | 118.50 | 277.00 | - | Reiterates |
| 03 Oct | Peel Hunt | Buy | 118.50 | 277.00 | - | Reiterates |
| 11 Sep | Peel Hunt | Buy | 118.50 | 277.00 | - | Reiterates |
| 04 Sep | Peel Hunt | Buy | 118.50 | 277.00 | - | Reiterates |
| Date | Director | Type | Volume / Price | Trade Value |
|---|---|---|---|---|
| 03 Aug 2017 | Alistair Gray | Buy | 3,848 @ 129.75p | £4,992.78 |
| 31 Jul 2017 | Dr Andrew Richards | Buy | 7,000 @ 146.88p | £10,281.60 |
| 18 Apr 2016 | Ali Mortazavi | Buy | 160,000 @ 125.00p | £200,000.00 |
| 18 Apr 2016 | Dr Stephen Parker | Buy | 6,478 @ 123.31p | £7,988.02 |
| 28 Nov 2012 | Ali Mortazavi | Buy | 2,400,000 @ 2.50p | £60,000.00 |
